Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - EyePoint Pharmaceuticals, Inc. | d643405dex312.htm |
| 10-K/A - 10-K/A - EyePoint Pharmaceuticals, Inc. | d643405d10ka.htm |
Exhibit 31.1
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
CERTIFICATIONS
I, Nancy Lurker, certify that:
| 1. | I have reviewed this Amendment to the Annual Report on Form 10-K of EyePoint Pharmaceuticals, Inc. for the fiscal year ended June 30, 2018; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: October 29, 2018
| /s/ Nancy Lurker | ||
| Name: | Nancy Lurker | |
| Title: | President and Chief Executive Officer | |
| (Principal Executive Officer) | ||
47